# FutureFuel Corp.: Form 10-Q for the period ended Mar 31, 2011

- Company: [FutureFuel Corp.](/companies/ff.md) (CIK 1337298)
- Form: 10-Q
- Filed: 2011-05-09
- Accepted by EDGAR: May 9, 2011, 10:34 ET
- Period: 2011-03-31
- Accession: 0001437749-11-002916
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1337298/000143774911002916/ff_10q-033111a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1337298/000143774911002916/

## Management's discussion and analysis

As filed, 25,911 characters.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read together with our consolidated financial statements, including the notes thereto, set forth herein. This discussion contains forward-looking statements that reflect our current views with respect to future events and financial performance. Actual results may differ materially from those anticipated in these forward-looking statements. See “Forward Looking Information” below for additional discussion regarding risks associated with forward-looking statements.

### Results of Operations

#### In General

We break our chemicals business into two main product groups: custom manufacturing and performance chemicals. Custom manufacturing consists of products made for specific customers based upon specifications provided by such customers. Major products in the custom manufacturing group include: (i) nonanoyloxybenzene-sulfonate, a bleach activator manufactured exclusively for The Procter & Gamble Company for use in a household detergent; and (ii) a proprietary herbicide (and intermediates) manufactured exclusively for Arysta LifeScience North America Corporation. The custom manufacturing group also includes agrochemicals as well as industrial and consumer products (cosmetics and personal care products, ink colorants, adhesion promoters, polymer additives, polymer and specialty dyes, specialty polymers, photographic and imaging chemicals, and food additives).

Revenues generated from the bleach activator are based on a supply agreement with the customer. The supply agreement stipulates selling price per kilogram based on volume sold, with price moving up as volumes move down, and vice-versa. The current contract expires in March 2013. We pay for raw materials required to produce the bleach activator. The contract with the customer provides that the price received by us for the bleach activator is indexed to changes in certain items, enabling us to pass along most inflationary increases in production costs to the customer.

We have been the primary manufacturer for our customer of a proprietary herbicide and certain intermediates. These products are facing generic competition, and no assurances can be given that we will remain the primary manufacturer for this product line. The contracts automatically renew for successive one-year periods, subject to the right of either party to terminate the contract not later than 270 days prior to the end of the then current term for the herbicide and not later than 18 months prior to the then current term for the intermediates. No assurances can be given that these contracts will not be terminated. The customer supplies most of the key raw materials for production of the proprietary herbicide. There is no pricing mechanism or specific protection against cost changes for raw materials or conversion costs that we are responsible for purchasing and/or providing.

In 2008, we entered into a contract with a new customer for the toll manufacture of an industrial intermediate utilized in the antimicrobial industry. We invested approximately $10 million in capital expenditures to modify and expand our plant to produce this industrial intermediate. The customer reimbursed these expenditures, which reimbursements have been classified as deferred revenue on our balance sheet and will be earned into income over the expected life of the product. The contract stipulates a price curve based on volumes sold and has an inflationary pricing provision whereby we pass along most inflationary changes in production costs to the customer. The contract expires in December 2013.

Pricing for the other custom manufacturing products is negotiated directly with the customer. Some, but not all, of these products have pricing mechanisms and/or protections against raw material or conversion cost changes.

Performance chemicals consist of specialty chemicals that are manufactured to general market-determined specifications and are sold to a broad customer base. The major product line in the performance chemicals group is SSIPA/LiSIPA, a polymer modifier that aids the properties of nylon. This group of products also includes sulfonated monomers and hydrotropes, specialty solvents, polymer additives, and chemical intermediates.

SSIPA/LiSIPA revenues are generated from a diverse customer base of nylon fiber manufacturers and other customers that produce condensation polymers. Contract sales are indexed to key raw materials for inflation; otherwise, there is no pricing mechanism or specific protection against raw material or conversion cost changes.

Pricing for the other performance chemical products is established based upon competitive market conditions. Some, but not all, of these products have pricing mechanism and/or specific protection against raw material or conversion cost changes.

We procure all of our own feedstock and only sell biodiesel for our own account. In rare instances, we purchase biodiesel from other producers for resale. We have the capability to process multiple types of vegetable oils and animal fats, we can receive feedstock by rail or truck, and we have completed the construction of substantial storage capacity to acquire feedstock at advantaged prices when market conditions permit. In 2009, we completed a project to increase our production capacity to 59 million gallons of biodiesel per year through the addition of a new continuous processing line. We initiated commercial production from this new line in May 2009. By the end of the second quarter of 2009, daily production volumes from the new processing line were demonstrated at approximately 80% of nameplate capacity. This production line was designed to produce biodiesel from feedstock with low fatty acids. We believe we successfully demonstrated our ability to keep this continuous processing line at or near capacity for sustained periods of time as well as our ability to procure and logistically handle large quantities of feedstock with low fatty acids. However, with the expiration of the $1.00 federal blender’s credit at the end of 2009, we determined that feedstock with low fatty acids were too costly to consistently produce biodiesel with positive margins. Accordingly, we redesigned our continuous line to produce biodiesel from feedstock with high fatty acids. We are still in the process of debugging this redesigned line.

There currently is uncertainty as to whether we will produce biodiesel in the future. This uncertainty results from: (i) changes in feedstock prices relative to biodiesel prices; (ii) continuance of the $1.00 per gallon federal blender’s tax credit, which credit terminates on December 31, 2011; and (iii) the permanency of government mandates. See “Risk Factors” below.

While biodiesel is the principal component of the biofuels segment, we also generate revenue from the sale of petrodiesel both in blends with our biodiesel and, from time to time, with no biodiesel added. Petrodiesel and biodiesel blends are available to customers at our leased storage facility in North Little Rock, Arkansas. In addition, we deliver blended product to a small group of customers within our region. We also sell refined petroleum products from time-to-time to maintain our status as a shipper on a common carrier pipeline.

The majority of our expenses are cost of goods sold. Cost of goods sold include raw material costs as well as both fixed and variable conversion costs, conversion costs being those expenses that are directly or indirectly related to the operation of our plant. Significant conversion costs include labor, benefits, energy, supplies, depreciation, and maintenance and repair. In addition to raw material and conversion costs, cost of goods sold includes environmental reserves and costs related to idle capacity. Finally, cost of goods sold includes hedging gains and losses recognized by us related to our biofuels segment. Cost of goods sold is allocated to the chemicals and biofuels business segments based on equipment and resource usage for most conversion costs and based on revenues for most other costs.

Operating costs include selling, general and administrative, and research and development expenses.

The discussion of results of operations that follows is based on revenues and expenses in total and for individual product lines and do not differentiate related party transactions.

#### Three Months Ended March 31, 2011 Compared to Three Months Ended March 31, 2010

#### Revenues

Revenues for the three months ended March 31, 2011 were $55,241,000 as compared to revenues for the three months ended March 31, 2010 of $47,763,000, an increase of 16%. Revenues from biofuels increased 153% and accounted for 19% of total revenues in the first quarter of 2011 as compared to 9% in the first quarter of 2010. Revenues from chemicals increased 3% and accounted for 81% of total revenues in the first quarter of 2011 as compared to 91% in the first quarter of 2010. Within the chemicals segment, revenues for the first quarter of 2011 changed as follows as compared to the first quarter of 2010: revenues from the bleach activator decreased 11%; revenues from the proprietary herbicide and intermediates increased 4%; revenues from CPOs increased 22%; revenues from DIPB increased 10%; and revenues from other products increased 20%.

Revenues from the bleach activator and the proprietary herbicide and intermediates are together the most significant components of our revenue base, accounting for 49% of revenues for the three months ended March 31, 2011 as compared to 61% for the three months ended March 31, 2010. The decrease in revenue from the bleach activator during the first quarter of 2011 as compared to the first quarter of 2010 was attributable to reduced volumes in 2011. The future volume of and revenues from the bleach activator depend on both consumer demand for the product containing the bleach activator and the manufacturing, sales, and marketing priorities of our customer. We are unable to predict with certainty the revenues we will receive from this product in the future.

Revenues from CPOs and DIPB together increased 15% during the first quarter of 2011 compared to the first quarter of 2010. The combined increased revenues from these two products were almost entirely attributable to increased CPOs sales volumes. The end market for CPOs is the automotive industry and demand for this product has benefited from the recent improvement in general economic conditions in the United States.

Increased revenues in the first quarter of 2011 compared to the first quarter of 2010 from the biofuels segment resulted from increased regional sales of blended biodiesel and unblended petrodiesel. The volumes of biodiesel and blended biodiesel sold in the first quarter of 2010 were limited due to the expiration of the $1.00 biodiesel blender’s credit. With the reinstatement of this credit in December 2010, biodiesel sales have resumed. The reinstatement of the biodiesel blender’s credit in December 2010 after its expiration in December 2009 makes a comparison of first quarter 2011 activity in the biofuel segment to first quarter 2010 activity meaningless.

#### Cost of Goods Sold and Distribution

Total cost of goods sold and distribution for the first three months of 2011 were $50,242,000 as compared to total cost of goods sold and distribution for the first three quarter of 2010 of $39,822,000, an increase of 26%.

Cost of goods sold and distribution for the first quarter of 2011 for our chemicals segment were $36,921,000 as compared to cost of goods sold and distribution for the first quarter of 2010 of $34,376,000. On a percentage basis, the 7% increase in cost of goods sold and distribution was higher than the 3% increase in chemicals segment revenues. The increase was primarily due to cost increases which we could not pass along to customers.

Cost of goods sold and distribution for the first quarter of 2011 for our biofuels segment were $13,321,000 as compared to cost of goods sold and distribution for the first quarter of 2010 of $5,446,000. On a percentage basis, cost of goods sold and distribution increased 145% versus an increase in revenues of 153%. This was due mostly to an increase in volume of product sold together with losses on derivative instruments. Such losses totaled $3,750,000 in the first three months of 2011 as compared to losses of $400,000 in the first three months of 2010. Our immediate recognition of derivative instrument gains and losses can cause our net income to be volatile from quarter to quarter due to the timing of the change in the derivative instrument relative to the sale of the biofuel.

#### Operating Expenses

Operating expenses decreased 18%, from $2,162,000 in the first three months of 2010 to $1,779,000 in the first three months of 2011. Compensation expense increased 11% as a result of an increase in work force. Research and development expense decreased 16% from $900,000 for the first three months of 2010 to $753,000 in 2011; this decrease was the result of a temporary shift in resources from research and development activities to plant support and capital projects.

#### Provision for Income Taxes

The effective tax rates for the three months ended March 31, 2011 and 2010 reflect our expected tax rate on reported operating earnings before income taxes. We have determined that we do not believe that we have a more likely than not probability of realizing a portion of our deferred tax assets. As such, we have recorded a valuation allowance of $308,000 at March 31, 2011 and $277,000 at December 31, 2010.

#### Critical Accounting Estimates

#### Revenue Recognition

For most product sales, revenue is recognized when product is shipped from our facilities and risk of loss and title have passed to the customer, which is in accordance with our customer contracts and the stated shipping terms. Nearly all custom manufactured products are manufactured under written contracts. Performance chemicals and biodiesel are generally sold pursuant to the terms of written purchase orders. In general, customers do not have any rights of return, except for quality disputes. However, all of our products are tested for quality before shipment, and historically returns have been inconsequential. We do not offer volume discounts, rebates, or warranties.

Revenue from bill and hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met. Bill and hold transactions for four specialty chemical products in the first quarters of 2011 and 2010 related to revenue that was recognized in accordance with contractual agreements based on product produced and ready for use. These sales were subject to written monthly purchase orders with agreement that production was reasonable. The inventory was custom manufactured and stored at the customer’s request and could not be sold to another buyer. Credit and payment terms for bill and hold customers are similar to other specialty chemical customers. Sales revenue under bill and hold arrangements were $15,040,000 and $14,614,000 for the three months ended March 31, 2011 and 2010, respectively.

### Liquidity and Capital Resources

Our net cash provided by (used in) operating activities, investing activities, and financing activities for the three months ended March 31, 2011 and 2010 are set forth in the following table.

(Dollars in thousands)

|  | March 31, 2011 | March 31, 2010 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $22,966 | $1,381 |
| Net cash used in investing activities | $(30,696) | $(8,075) |
| Net cash provided by (used in) financing activities | $(3,964) | $45,777 |

#### Operating Activities

Cash provided by operating activities increased from $1,381,000 during the first three months of 2010 to $22,966,000 during the first three months of 2011. Cash provided by (used in) the change in accounts receivable increased from $(2,973,000) in the first three months of 2010 to $8,114,000 in the first three months of 2011. This increase was primarily attributable to the collection of the $1.00 per gallon biodiesel blender’s credit which was booked as an accounts receivable at December 31, 2010. Cash provided by (used in) the change in accounts payable increased from $(3,697,000) in the first three months of 2010 to $7,853,000 in the first three months of 2011. This increase was largely attributable to the timing of payments related to purchases of inventory and capital expenditures. In addition, cash provided by the change in deferred revenue increased from $2,081,000 in the first three months of 2010 to $5,277,000 in the first three months of 2011, a result of the progress made on capital projects we have undertaken on behalf of our customers. Offsetting these increases in cash provided by operating activities is an increase in the cash used for inventories. Such usage increased from $(2,737,000) in the three months ended March 31, 2010 to $(3,827,000) in the three months ended March 31, 2011. This increase in inventories is largely the result of a build in biodiesel feed stocks.

#### Investing Activities

Cash used in investing activities increased from $8,075,000 in the first three months of 2010 to $30,696,000 in the first three months of 2011. This increase was primarily attributable to our investing activities as cash used in the purchase of marketable securities increased from $6,034,000 in the first three months of 2010 to $58,311,000 in the first three months of 2011. Partially offsetting this increase in cash used are increases in cash provided by investing activities totaling $16,400,000 and $19,577,000 related to activity in our restricted cash account and sales of marketable securities in the first three months of 2011.

#### Financing Activities

Cash provided by (used in) financing activities decreased from $45,777,000 in the first quarter of 2010 to $(3,964,000) in the first quarter of 2011. This change is primarily the result of a lack of warrants to purchase shares of our common stock being exercised in the first three months of 2011 as they were in the first three months of 2010. The warrants issued by us in 2006 expired in July 2010. Additionally, we paid a special cash dividend in the first quarter of 2011 in the aggregate amount of $3,999,000. No such dividend was paid in the first three months of 2010.

#### Credit Facility

We entered into a $50 million credit agreement with a commercial bank in March 2007. The loan is a revolving facility the proceeds of which may be used for our working capital, capital expenditures, and general corporate purposes. The facility terminates on June 30, 2013. Advances are made pursuant to a borrowing base. Advances are secured by a perfected first priority security interest in our accounts receivable and inventory. The interest rate floats at certain margins over LIBOR or base rate based upon the leverage ratio from time to time. There is an unused commitment fee. The ratio of total funded debt to EBITDA may not be less than 3:1. We had no borrowings under this credit agreement at March 31, 2011 or December 31, 2010.

We intend to fund future capital requirements for our businesses from cash flow generated by us as well as from existing cash and cash investments and borrowings under the credit facility. We do not believe there will be a need to issue any securities to fund such capital requirements.

#### Special Dividend

In the first quarter of 2011, we declared a special cash dividend in the amount of $0.10 per share on our common stock, with a record date of March 1, 2011 and a payment date of March 15, 2011. The special cash dividend amounted to approximately $3,999,000.

#### Capital Management

As a result of our initial equity offering, our subsequent positive operating results, and the exercise of warrants, we accumulated excess working capital. Some of this excess working capital was paid out in 2008, 2009, 2010, and the first quarter of 2011 as a special cash dividend. We intend to retain the remaining cash to fund infrastructure and capacity expansion at our Batesville plant and to pursue complementary acquisitions in the energy and chemical industries. Third parties have not placed significant restrictions on our working capital management decisions.

These funds were predominantly held in cash or cash equivalents at multiple financial institutions. In the first quarter of 2011 and in 2010, we also had investments in certain preferred stock, trust preferred securities, and other equity instruments. We classify these investments as current assets in the accompanying consolidated balance sheets and designate them as being “available-for-sale”. Accordingly, they are recorded at fair value, with the unrealized gains and losses, net of taxes, reported as a component of stockholders’ equity. The fair value of these preferred stock, trust preferred securities, and other equity instruments, including accrued interest, totaled $52,014,000 and $28,200,000 at March 31, 2011 and December 31, 2010, respectively.

At March 31, 2011 and December 31, 2010, we also had a short position in certain marketable debt securities. The purpose of this position was to help mitigate the potential negative impact an increase in interest rates would have on other marketable securities we had purchased. The securities comprising this position are carried at fair value, with unrealized gains and losses reported as a component of net income. We realized losses of $69,000 on these securities in the first quarter of 2011. No such losses were recognized the first quarter of 2010. The fair value of these securities totaled $(2,579,000) and $(19,295,000) at March 31, 2011 and December 31, 2010, respectively. The margin account maintained with a broker to collateralize these securities carried a balance of $4,685,000 and $21,086,000 at March 31, 2011 and December 31, 2010, respectively, and is classified as restricted cash and cash equivalents in the consolidated balance sheet.

Lastly, we maintain depository accounts such as checking accounts, money market accounts, and other similar accounts at selected financial institutions.

### Off-Balance Sheet Arrangements

We engage in two types of hedging transactions. First, we hedge our biofuels sales through the purchase and sale of futures contracts and options on futures contracts of energy commodities. This activity was captured on our balance sheet at March 31, 2011 and December 31, 2010. Second, we hedge our biofuels feedstock through the execution of purchase contracts and supply agreements with certain vendors. These hedging transactions are recognized in earnings and were not recorded on our balance sheet at March 31, 2011 or December 31, 2010 as they do not meet the definition of a derivative instrument as defined under accounting principles generally accepted in the U.S. The purchase of biofuels feedstock generally involves two components: basis and price. Basis covers any refining or processing required as well as transportation. Price covers the purchases of the actual agricultural commodity. Both basis and price fluctuate over time. A supply agreement with a vendor constitutes a hedge when we have committed to a certain volume of feedstock in a future period and have fixed the basis for that volume.

At March 31, 2011 and December 31, 2010, we had a short position in certain marketable debt securities. The purpose of this position was to help mitigate the potential negative impact an increase in interest rates would have on other marketable securities we have purchased. We are committed to repurchase these short-sold securities in the future. We are required to maintain a margin account at a broker to collateralize this obligation. It is possible that this margin account balance will not be sufficient to meet our obligations, which would place an additional commitment on our available cash balances.

### Other Matters

We entered into an agreement with a customer to construct at a fixed price a processing plant and produce a certain chemical for the customer. We engaged a third party to act as general contractor on the construction of this plant for a guaranteed price. That general contractor defaulted on its obligations under its contract with us and abandoned the project. As a result, we undertook the general contractor role ourselves. We also filed suit against our former contractor to recoup any damages that we may incur as a result of his default. The former contractor counterclaimed against us for amounts he asserts are due him under our contract with him. At this time, we are unable to determine what effect the general contractor’s default and/or his counterclaim will have on us or on our financial condition.

We entered into an agreement with a biodiesel trade association to pay certain fees and dues to the association in order to obtain access and registration to the association’s compiled biodiesel health effects data (“***HED”***) required by the Environmental Protection Agency for biodiesel manufacturers. Manufacturers of biodiesel who pay their fair share of costs for the HED can have access to and obtain registration with the Environmental Protection Agency. We brought suit against the trade association for rescission of the agreement for various reasons including, among other things, that we already paid our fair share of costs for the data to the trade association; and that the fees and dues structure of the trade association were overly excessive and against public policy. The trade association filed suit against us for collection of alleged fees and dues owed by us to it. At this time, we are unable to determine what effect the trade association’s suit against us will have on us or on our financial condition.

## Market risk

As filed, 5,543 characters.

In recent years, general economic inflation has not had a material adverse impact on our costs and, as described elsewhere herein, we have passed some price increases along to our customers. However, we are subject to certain market risks as described below.

Market risk represents the potential loss arising from adverse changes in market rates and prices. Commodity price risk is inherent in the chemical and biofuels business both with respect to input (electricity, coal, biofuels feedstock, etc.) and output (manufactured chemicals and biofuels).

We seek to mitigate our market risks associated with the manufacturing and sale of chemicals by entering into term sale contracts that include contractual market price adjustment protections to allow changes in market prices of key raw materials to be passed on to the customer. Such price protections are not always obtained, however, so raw material price risk remains significant.

In order to manage price risk caused by market fluctuations in biofuels prices, we may enter into exchange traded commodity futures and options contracts. We account for these derivative instruments in accordance with ASC 815-20-25, *Derivatives and Hedging, Hedging-General, Recognition.* Under this standard, the accounting for changes in the fair value of a derivative instrument depends upon whether it has been designated as an accounting hedging relationship and, further, on the type of hedging relationship. To qualify for designation as an accounting hedging relationship, specific criteria must be met and appropriate documentation maintained. We had no derivative instruments that qualified under these rules as designated accounting hedges in the first quarter of 2011 or 2010. Changes in the fair value of our derivative instruments are recognized at the end of each accounting period and recorded in the statement of operations as a component of cost of goods sold.

Our immediate recognition of derivative instrument gains and losses can cause net income to be volatile from quarter to quarter due to the timing of the change in value of the derivative instruments relative to the sale of biofuel being sold. As of March 31, 2011 and December 31, 2010, the fair values of our derivative instruments were a net liability in the amount of $1,812,000 and $1,649,000, respectively.

Our gross profit will be impacted by the prices we pay for raw materials and conversion costs (costs incurred in the production of chemicals and biofuels) for which we do not possess contractual market price adjustment protection. These items are principally comprised of animal fat, electricity, and petrodiesel. The availability and price of these items are subject to wide fluctuations due to unpredictable factors such as weather conditions, overall economic conditions, governmental policies, commodity markets, and global supply and demand.

We prepared a sensitivity analysis of our exposure to market risk with respect to key raw materials and conversion costs for which we do not possess contractual market price adjustment protections, based on average prices for the first three months of 2011. We included only those raw materials and conversion costs for which a hypothetical adverse change in price would result in a 1% or greater decrease in gross profit. Assuming that the prices of the associated finished goods could not be increased and assuming no change in quantities sold, a hypothetical 10% change in the average price of the commodity listed below would result in the following change in annual gross profit.

(Volumes and dollars in thousands)

| Item | Volume(a) Requirements | Units | Hypothetical Adverse Change in Price | Decrease in Gross Profit | Percentage Decrease in Gross Profit |
| --- | ---: | --- | ---: | ---: | ---: |
| Animal fat | 11,251,669 | LB | 10% | $387 | 7.7% |
| Ultra low sulphur diesel | 1,070,167 | GAL | 10% | $253 | 5.1% |
| Natural gas | 263,606 | MCF | 10% | $129 | 2.6% |
| Electricity | 22,085 | MWH | 10% | $113 | 2.3% |
| Proprionic anhydride | 958,292 | LB | 10% | $98 | 2.0% |
| Caustic soda | 6,153,212 | LB | 10% | $82 | 1.6% |

(a) Volume requirements and average price information are based upon volumes used and prices obtained for the three months ended March 31, 2011. Volume requirements may differ materially from these quantities in future years as our business evolves.

We had no borrowings as of March 31, 2011 or December 31, 2010 and, as such, we were not exposed to interest rate risk for those years. Due to the relative insignificance of transactions denominated in a foreign currency, we consider our foreign currency risk to be immaterial.

At March 31, 2011 and December 31, 2010, we had a short position in certain marketable debt securities. The purpose of this position was to help mitigate the potential negative impact an increase in interest rates would have on our other marketable securities. The fair value of the securities totaled $(2,579,000) and $(19,295,000) at March 31, 2011 and December 31, 2010, respectively. We maintain a margin account to collateralize these marketable debt securities. This margin account maintained a balance of $4,685,000 and $21,086,000 at March 31, 2011 and December 31, 2010, respectively, and is classified as restricted cash and cash equivalents in our consolidated balance sheet included herein. We will be obligated to purchase these securities at a future date. To the extent that these marketable debt securities appreciate in value, we are exposed to off-balance sheet risks.

## Controls and procedures

As filed, 1,146 characters.

This section could not be read just now; read it on sec.gov.

## Risk factors

As filed, 253 characters.

This section could not be read just now; read it on sec.gov.

Filed May 9, 2011.
Source: SEC EDGAR, the filing index for accession 0001437749-11-002916. Last ingested by Listed: Nov 14, 2026, 19:59 ET. No prices; not investment advice.
